Estimates Revisions PharmaEssentia Corporation Deutsche Boerse AG
Stocks
8Z1
US7169722037
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.50 EUR | -.--% |
|
+11.00% | - |
| 07-09 | PharmaEssentia Swings to Profit in May as Revenue Balloons 108% | MT |
| 06-18 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 6446 Stock
- 8Z1 Stock
- Consensus PharmaEssentia Corporation
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
